Seeking Alpha

Monsanto Company (MON)

  • Oct. 3, 2012, 12:05 AM
    Notable earnings before Wednesday’s open: FDO, MON, RPM
    | Comment!
  • Oct. 2, 2012, 5:30 PM
    Notable earnings before Wednesday’s open: FDO, MON, RPM
    | Comment!
  • Sep. 28, 2012, 11:13 AM
    Monsanto's (MON -0.2%) genetically engineered NK603 corn should be banned in South Africa because it is hazardous to the health, according to the African Centre for Biosafety, following a French study that found the product caused cancer in rats. White corn is a staple food in South Africa, where genetically modified plants accounted for 80% of the harvest last year.
  • Sep. 27, 2012, 9:07 AM
    Monsanto (MON) +1.5% premarket after Wells Fargo upgrades shares to Outperform with a $104-$106 target price range, up from $82-$84: "With Chinese glyphosate challenges seemingly well behind them, we expect MON to benefit from higher seed pricing (up 5-10% in FY2013) and penetration in Latin America (through the introduction of double and triple stacked traits)."
    | Comment!
  • Sep. 25, 2012, 11:38 AM
    Russia suspends the import and sales of Monsanto's (MON) genetically modified NK603 corn until the country gets further information on the safety of the products. Scientists at Russia’s Institute of Nutrition are asked to review the French study which raised questions about the long-term effect of MON’s NK 603 corn on rats.
    | Comment!
  • Sep. 20, 2012, 9:34 AM
    Austrian agriculture minister Niki Berlakovich calls on the European Commission to review its approval process for GM food after a controversial two-year French study linked Monsanto's (MON) corn to increased cancer in rats. France's government has asked its health regulator to analyze the findings, although some scientists questioned the study's methodology.
    | 1 Comment
  • Sep. 19, 2012, 3:39 PM
    "Monsanto’s (MON +2.8%) doing a lot of things right," OptionMonster’s Jon Najarian tells CNBC, adding the stock's two-year rise could continue as demand grows for MON’s genetically engineered, drought-resistant seeds. Shares are strong today, as investors focus on Goldman's upgrade rather than a study that said rats developed tumors after being exposed to certain MON products.
  • Sep. 19, 2012, 7:51 AM
    Rats fed with Monsanto's (MON +1.7%) GM corn in a French  study, or exposed to its Roundup weedkiller, suffered mammary tumors, and severe liver and kidney damage. Around 50% of males and 70% of females died prematurely vs. 30% and 20% in the control group. However, the lead researcher has a record as a critic of the GM industry, so other experts may be wary of drawing quick conclusions.
  • Sep. 19, 2012, 7:19 AM
    Goldman Sachs adds Monsanto (MON) to its Conviction Buy List with renewed confidence that the company can deliver EPS growth of around 20% in the next few years. A price target of $110 from Goldman analysts reps 24% upside on shares. MON +1.1% premarket to $90.01.
    | Comment!
  • Sep. 13, 2012, 11:20 AM
    Given the drought, scary-low ending grain stocks, and record farm incomes, how much longer will the companies selling stuff to farmers underperform the broader market? The Agribusiness ETF (MOO) has had a decent summer, but has fallen behind the S&P by 2000 basis points over the last year. Top holdings include: Monsanto, Potash, and Deere.
  • Sep. 5, 2012, 5:04 AM
    Evidence is mounting that Monsanto's (MON) genetically modified corn is losing its effectiveness to bugs, the EPA says, with studies finding that rootworms on two Illinois farms had become resistant to insecticide that the corn produces. Corn accounted for $4.81B of Monsanto's sales last year, or 41% of the total.
  • Sep. 4, 2012, 4:41 PM
    The principal grains producers' association in Brazil's top soybean-growing state warns farmers not to plant a new variety of transgenic soy it says Monsanto (MON) is distributing. The soy hasn't been approved in China, where most of Brazil's exports of the oilseed are shipped; the group claims seeds could contaminate shipments of approved varieties, putting exports to China at risk of being refused.
    | Comment!
  • Aug. 28, 2012, 9:43 AM
    Monsanto (MON -0.4%) signs a deal with Alnylam Pharmaceuticals (ALNY +3.6%) to use the biopharma's gene-silencing technology to improve its biopesticides. MON gains exclusive rights to use ALNY's platform technology and intellectual property; ALNY will receive $29M in upfront payments plus milestone payments and research funding.
    | Comment!
  • Aug. 27, 2012, 3:57 PM
    Monsanto (MON +1%) moves higher after announcing that a new testing program from its Integrated Farming System platform is set to launch next year. MON says the platform is designed to provide farmers with a valuable new approach to boost on-farm productivity while also supporting more sustainable global agriculture systems.
    | Comment!
  • Aug. 22, 2012, 12:27 PM
    A coalition opposed to California's Proposition 37 has collected $25M from corporate backers including Monsanto (MON), DuPont (DD), PepsiCo (PEP) and Coca-Cola (KO), more than any other initiative. The legislation, if approved, would make California the first state to require labels on genetically engineered crops or processed foods that contain genetically engineered fruits or vegetables, such as corn, soybeans, sugar beets and Hawaiian papayas.
  • Aug. 20, 2012, 2:18 PM
    UBS hikes its target price for Monsanto (MON -0.7%) to $88 from $80 but maintains its Neutral rating on valuation. The firm raises its EPS estimates to $4.40 from $4.25 for 2013 and to $4.95 from $4.55 for 2014 (maintains 2012 at $3.70), citing its product portfolio and pipeline. Also, MON promotes 29-year company veteran Brett Begemann to president.
    | Comment!
Visit Seeking Alpha's
MON vs. ETF Alternatives
Company Description
Monsanto Co is a provider of agricultural products for farmers. The Company offers corn, soybean, cotton, wheat, canola, sorghum and sugar cane seeds. Its segments are Seeds and Genomics and Agricultural Productivity.